From Big Data to Big Breakthroughs: Caleb Webber on Parkinson’s
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Caleb is the Director of Informatics at the UK Dementia Research Institute and a leading voice in decoding the complexities of neurodegenerative disease. He reveals groundbreaking findings from his team’s work: surprising overlaps between Parkinson’s and diabetes, the discovery that existing hypertension medications may halve the risk of developing Parkinson’s, and a major new study exploring whether combining blood-pressure drugs with GLP-1 therapies (like Ozempic-type medications) could slow or even prevent the disease.
Caleb offers real reasons for optimism: that prevention may be within reach, that repurposed medications could help people sooner than expected, and that the next decade of brain-health research looks more promising than any before.
This is an episode filled with science, humanity, and genuine hope — for people living with Parkinson’s today, for those caring for them, and for anyone navigating life touched by neurodegenerative disease.
We'd love to hear your stories and your advice for anyone living with dementia - or if you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit
https://www.alzheimers.org.uk
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.